documents: FDA-2014-D-2175-0006
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2014-D-2175-0006 | FDA | FDA-2014-D-2175 | Reference 3 Mitchell-1984-Physicochemical Inactivation of Lassa, Ebola, and Marburg Viruses and Effect on Clinical Laboratory Analyses re Recommendations for Assessment of Blood Donor Suitability, Donor Deferral and Blood Product Management in Response to Ebola Virus; Draft Guidance for Industry; Availability | Supporting & Related Material | Background Material | 2015-12-07T05:00:00Z | 2015 | 12 | 2015-12-07T14:38:57Z | 0 | 0 | 0900006481d83cbb |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref